Cytek Biosciences (CTKB) Short Interest Ratio & Short Volume → Thousands of investors use this no cost solution | Do you? (From Insider Financial) (Ad) Free CTKB Stock Alerts $5.63 -0.03 (-0.53%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cytek Biosciences Short Interest DataCurrent Short Volume7,470,000 sharesPrevious Short Volume9,950,000 sharesChange Vs. Previous Month-24.92%Dollar Volume Sold Short$44.97 millionShort Interest Ratio / Days to Cover10.8Last Record DateApril 15, 2024Outstanding Shares130,820,000 sharesFloat Size118,770,000 sharesShort Percent of Float6.29%Today's Trading Volume541,272 sharesAverage Trading Volume730,812 sharesToday's Volume Vs. Average74% Short Selling Cytek Biosciences ? Sign up to receive the latest short interest report for Cytek Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCTKB Short Interest Over TimeCTKB Days to Cover Over TimeCTKB Percentage of Float Shorted Over Time Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. Cytek Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20247,470,000 shares $44.97 million -24.9%6.3%10.8 $6.02 3/31/20249,950,000 shares $66.76 million +16.9%8.4%13.8 $6.71 3/15/20248,510,000 shares $59.14 million +9.2%7.1%11.6 $6.95 2/29/20247,790,000 shares $59.98 million +4.6%6.3%10.2 $7.70 2/15/20247,450,000 shares $64.96 million -2.5%6.3%9.1 $8.72 1/31/20247,640,000 shares $57.68 million No Change6.6%8.1 $7.55 Get the Latest News and Ratings for CTKB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cytek Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20247,640,000 shares $62.72 million +5.2%6.6%7.1 $8.21 12/31/20237,260,000 shares $66.21 million -5.2%6.3%6.5 $9.12 12/15/20237,660,000 shares $69.55 million -3.8%6.6%7.1 $9.08 11/30/20237,960,000 shares $55.24 million -5.0%6.9%7.2 $6.94 11/15/20238,380,000 shares $47.85 million +5.8%7.2%7.8 $5.71 10/31/20237,920,000 shares $33.34 million +0.6%6.8%8.1 $4.21 10/15/20237,870,000 shares $39.51 million -2.8%6.7%8.9 $5.02 9/30/20238,100,000 shares $44.71 million -31.8%6.9%9.5 $5.52 9/15/202311,880,000 shares $83.16 million +0.5%10.4%14.2 $7.00 8/31/202311,820,000 shares $89.83 million +2.7%10.3%14.8 $7.60 8/15/202311,510,000 shares $100.25 million -4.2%10.1%15.2 $8.71 7/31/202312,020,000 shares $107.70 million +4.9%11.0%12.3 $8.96 7/15/202311,460,000 shares $103.25 million +9.4%10.5%8.3 $9.01 6/30/202310,480,000 shares $89.50 million +11.4%9.6%7.6 $8.54 6/15/20239,410,000 shares $81.68 million +8.4%8.6%6.8 $8.68 5/31/20238,680,000 shares $67.79 million -22.6%8.0%6.5 $7.81 5/15/202311,210,000 shares $81.61 million +66.1%10.3%8.3 $7.28 4/30/20236,750,000 shares $77.49 million +3.7%7.2%6.2 $11.48 4/15/20236,510,000 shares $66.27 million +15.2%6.0%9.6 $10.18 3/31/20235,650,000 shares $51.92 million -2.4%5.2%8.2 $9.19 3/15/20235,790,000 shares $56.16 million +1.1%5.3%8.3 $9.70 2/28/20235,730,000 shares $59.02 million +4.4%5.3%8.8 $10.30 2/15/20235,490,000 shares $65.50 million +7.7%5.2%8.8 $11.93 1/31/20235,100,000 shares $61.46 million +28.5%5.6%8.3 $12.05 1/15/20233,970,000 shares $43.63 million +9.7%4.3%6.6 $10.99 12/30/20223,620,000 shares $36.96 million +4.3%4.3%6.5 $10.21 12/15/20223,470,000 shares $37.44 million +20.9%4.1%5.9 $10.79 11/30/20222,870,000 shares $36.99 million +3.6%3.4%4.4 $12.89 11/15/20222,770,000 shares $40.86 million -14.8%3.3%4.1 $14.75 10/31/20223,250,000 shares $50.44 million -13.8%4.4%4.8 $15.52 10/15/20223,770,000 shares $54.25 million -9.4%5.0%5.6 $14.39 9/30/20224,160,000 shares $61.24 million +51.3%5.6%6.2 $14.72 9/15/20222,750,000 shares $38.20 million +3.8%3.7%4 $13.89 8/31/20222,650,000 shares $30.87 million -4.0%3.6%4.3 $11.65The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. CTKB Short Interest - Frequently Asked Questions What is Cytek Biosciences' current short interest? Short interest is the volume of Cytek Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 7,470,000 shares of CTKB short. 6.29% of Cytek Biosciences' shares are currently sold short. Learn More on Cytek Biosciences' current short interest. What is a good short interest ratio for Cytek Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTKB shares currently have a short interest ratio of 11.0. Learn More on Cytek Biosciences's short interest ratio. What is a good short interest percentage for Cytek Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.29% of Cytek Biosciences' floating shares are currently sold short. Is Cytek Biosciences' short interest increasing or decreasing? Cytek Biosciences saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 7,470,000 shares, a decline of 24.9% from the previous total of 9,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cytek Biosciences' float size? Cytek Biosciences currently has issued a total of 130,820,000 shares. Some of Cytek Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cytek Biosciences currently has a public float of 118,770,000 shares. How does Cytek Biosciences' short interest compare to its competitors? 6.29% of Cytek Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Cytek Biosciences: Standard BioTools Inc. (3.05%), EyePoint Pharmaceuticals, Inc. (13.12%), Quanterix Co. (3.21%), Allogene Therapeutics, Inc. (29.95%), Valneva SE (0.07%), Prothena Co. plc (12.34%), Pacific Biosciences of California, Inc. (18.11%), Nautilus Biotechnology, Inc. (1.95%), Myriad Genetics, Inc. (6.08%), Olink Holding AB (publ) (2.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Cytek Biosciences stock? Short selling CTKB is an investing strategy that aims to generate trading profit from Cytek Biosciences as its price is falling. CTKB shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cytek Biosciences? A short squeeze for Cytek Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CTKB, which in turn drives the price of the stock up even further. How often is Cytek Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTKB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Standard BioTools Short Interest EyePoint Pharmaceuticals Short Interest Quanterix Short Interest Allogene Therapeutics Short Interest Valneva Short Interest Prothena Short Interest Pacific Biosciences of California Short Interest Nautilus Biotechnology Short Interest Myriad Genetics Short Interest Olink Holding AB (publ) Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CTKB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsKeep Your Eyes on This Power-Mad PoliticianAltimetryThe Next Nvidia?InvestorPlace